Jared Barrera - 22 Sep 2025 Form 4 Insider Report for Kindly MD, Inc. (KDLY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Sep 2025, 21:52:54 UTC
Prior SEC filing
14 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kyle Simon, as attorney-in-fact

Key filing fact

Jared Barrera filed Form 4 for Kindly MD, Inc. (KDLY) on 24 Sep 2025.

Key facts

  • This page summarizes Jared Barrera's Form 4 filing for Kindly MD, Inc. (KDLY).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Sep 2025, 21:52.

Change

  • Previous filing in this sequence was filed on 14 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002002864 Primary reporting owner

Barrera Jared

Relationship
Chief Financial Officer
Address
5097 SOUTH 900 EAST, SUITE 100, SALT LAKE CITY
Signature
/s/ Kyle Simon, as attorney-in-fact
Signature date
24 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAKA transaction

Common Stock

Award

Transaction value
$0
Shares
+6,400
Change %
+40%
Price
$0.000000
Shares after
22,242
Date
22 Sep 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This reflects a restricted stock award that was fully vested as of September 22, 2025.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .